First Deaths in Vaccine Tests and Flu Vaccine Program

Published:  




The first death occurred during the tests of anti-Wuhan vaccine in Brasil, and five South Koreans died after being vaccinated with flu shots.



The first public information of about death during the 2nd stage of the tests of anti-Wuhan virus vaccination was published on Thursday, after 28 years old participant of the program in Brasil has passed away.

The information about the company and the name of the tested vaccine have not been immediately published.

Five people have died after getting flu shots in South Korea in the past week, authorities said, raising concerns over the vaccine’s safety.

The deaths include a 17-year-old boy and a man in his 70s.

The vaccination program was suspended over safety worries. The deaths have dominated headlines in South Korea on Thursday.

The vaccines were supplied by the drugmakers, including LG Chem Ltd and Boryung Biopharma Co. Ltd., a unit of Boryung Pharm Co. Ltd.

The investigation, including  postmortems, was underway. “It makes it hard for us to put out a categorical statement,” Vice Health Minister Kim Gang-lip told a briefing on Wednesday about the deaths.

But some virologists suggested that those vaccinated might have been asymptomatic Wuhan virus carriers.


 


Go back

Economy & Investment

Economy. Markets

Investment Loans Cost To Raise In 2024

The 2024 can hold surprises for traders as the world adjusts to an economic order where money is not cheap.

ℑ   3 min read

Economy. Markets

Investment Loans Cost To Raise In 2024

The 2024 can hold surprises for traders as the world adjusts to an economic order where money is not cheap.

ℑ   3 min read

Economy. Markets

Investment Loans Cost To Raise In 2024

The 2024 can hold surprises for traders as the world adjusts to an economic order where money is not cheap.

ℑ   3 min read

Economy. Markets

Investment Loans Cost To Raise In 2024

The 2024 can hold surprises for traders as the world adjusts to an economic order where money is not cheap.

ℑ   3 min read